Repligen (FRA:RGN) Other Current Liabilities : €60.7 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Repligen Other Current Liabilities?

Repligen's other current liabilities for the quarter that ended in Mar. 2025 was €60.7 Mil.

Repligen's quarterly other current liabilities increased from Sep. 2024 (€37.9 Mil) to Dec. 2024 (€47.1 Mil) and increased from Dec. 2024 (€47.1 Mil) to Mar. 2025 (€60.7 Mil).

Repligen's annual other current liabilities declined from Dec. 2022 (€44.8 Mil) to Dec. 2023 (€27.2 Mil) but then increased from Dec. 2023 (€27.2 Mil) to Dec. 2024 (€47.1 Mil).

Repligen Other Current Liabilities Historical Data

The historical data trend for Repligen's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Repligen Other Current Liabilities Chart

Repligen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

16.68

37.30

44.81

27.18

47.07

Repligen Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Liabilities	Get a 7-Day Free Trial															41.29	34.72	37.88	47.07	60.65

Repligen Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Repligen Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Repligen's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Repligen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Repligen Corp (FRA:RGN) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

RGEN:USA RGN:Germany

Address

41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453

Website

https://www.repligen.com

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Repligen Headlines

No Headlines